Brunner, Patrick M.
Suárez-Fariñas, Mayte
He, Helen
Malik, Kunal
Wen, Huei-Chi
Gonzalez, Juana
Chan, Tom Chih-Chieh
Estrada, Yeriel
Zheng, Xiuzhong
Khattri, Saakshi
Dattola, Annunziata
Krueger, James G.
Guttman-Yassky, Emma
Article History
Received: 2 May 2017
Accepted: 24 July 2017
First Online: 18 August 2017
Change Date: 29 May 2018
Change Type: Correction
Change Details: A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.
Competing Interests
: PMB has received personal fees from LEO Pharma and Sanofi. MSF has received research support from Pfizer and Quorum Consulting. JGK has received research support (grants paid to his institution) and/or personal fees from Pfizer, Amgen, Janssen, Lilly, Merck, Novartis, Kadmon, Dermira, Boehringer, Innovaderm, Kyowa, BMS, Serono, BiogenIdec, Delenex, AbbVie, Sanofi, Baxter, Paraxel, Xenoport, and Kineta. EGY is a board member for Sanofi Aventis,Regeneron,Stiefel/GlaxoSmithKline,MedImmune, Celgene, Anacor, AnaptysBio, Celsus, Dermira,Galderma,Glenmark,Novartis, Pfizer, Vitae, Leo Pharma, Abbvie and Asana Biosciences; has received consultancy fees from Regeneron, Sanofi, MedImmune, Celgene, Stiefel/GlaxoSmithKline, Celsus, BMS, Amgen, Drais, AbbVie, Anacor, AnaptysBio, Dermira, Galderma, Glenmark, LEO Pharma, Novartis, Pfizer, Vitae, Mitsubishi Tanabe, Eli Lilly, Abbvie, and Asana Biosciences; and has received research support from Janssen, Regeneron, Celgene, BMS, Novartis, Merck, LEO Pharma, Dermira, Glenmark, Innovaderm, and UCB. The rest of the authors declare that they have no relevant conflicts of interest.